Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of Immune Response of Twinrix Vaccine in Children
NCT00197184Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Mar 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of hepatitis b vaccine recombinant in hepatitis A (HAV) and hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoints: Anti-hepatitis A (HAV) Antibody Concentrations at Year 5, Anti-hepatitis B (HBs) Antibody Concentrations at Year 5 and 2 more. Started Nov 2003; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00197184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197184.